Nyra Medical, a leading innovator in structural heart therapies, announced two key executive appointments that further solidify the company’s momentum as it advances its revolutionary Cardiac
Feedback from recent FDA interaction indicates that a confirmatory Phase 3 trial evaluating apraglutide in SBS-IF is needed to seek approval Ironwood Pharmaceuticals, Inc., a
A novel approach to disease prevention and treatment, precision medicine—also referred to as “personalized medicine”—considers variations in people’s genes, environments, and lifestyles. Using biomarkers to separate patients in clinical trials to improve effectiveness and/or
Seoul Medical Group (SMG) and Korean American Medical Group (KAMG), the two leading Asian-American-focused medical groups and physician networks in the United States, announced that
CitiusTech, a leading provider of healthcare technology, services & solutions, announced the launch of a highly scalable and integrated Real-World Data (RWD) platform designed for
Atropos Health, a pioneer in translating clinical data into personalized real-world evidence (RWE) and insights, announced its selection by Emory Healthcare, an academic health system
athenahealth, a leading provider of network-enabled software and services for healthcare practices and systems nationwide, announced a partnership with Abridge, the leading generative AI platform
DeepScribe, a leader in ambient AI for specialty care, and Flatiron Health, a healthtech innovator in oncology solutions, announced a partnership to integrate DeepScribe’s AI
Biome Analytics has launched the Heart Failure Performance Module, a new addition to its Foundations Reporting platform. This tool is designed to help healthcare professionals
Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers, has announced that it will partner with Beacon Health
Fuel up with free Health Tech Insights
